Evidence map›Paper›PMID 40567826›Full record

ArticleFrontiers in cardiovascular medicine2025

Two-year follow-up of patients with myocardial injury during acute COVID-19: insights from the CARDIO COVID 20-21 registry.

Juan Pablo Arango-Ibanez, Brayan Daniel Cordoba-Melo, Mario Miguel Barbosa Rengifo, Jesika Daniela Tobar-Arteaga, Maria Lucia Castro-Trujillo, Cesar José Herrera, Miguel Ángel Quintana Da Silva, Andrés Felipe Buitrago Sandoval, María Lorena Coronel Gilio, Freddy Pow Chon Long and 4 more

Abstract read
In one paragraph

Article in Frontiers in cardiovascular medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Juan Pablo Arango-IbanezCentro de Investigaciones Clínicas, Fundación Valle del Lili, Cali, Valle del Cauca, Colombia.
Brayan Daniel Cordoba-MeloCentro de Investigaciones Clínicas, Fundación Valle del Lili, Cali, Valle del Cauca, Colombia.
Mario Miguel Barbosa RengifoCentro de Investigaciones Clínicas, Fundación Valle del Lili, Cali, Valle del Cauca, Colombia.
Jesika Daniela Tobar-ArteagaFacultad de Ciencias de la Salud, Universidad Icesi, Cali, Valle del Cauca, Colombia.
Maria Lucia Castro-TrujilloFacultad de Ciencias de la Salud, Universidad Icesi, Cali, Valle del Cauca, Colombia.
Cesar José HerreraDepartamento de Cardiología, Centros de Diagnóstico y Medicina Avanzada y de Conferencias Médicas y Telemedicina (CEDIMAT), Santo Domingo, República Dominicana.
Miguel Ángel Quintana Da SilvaDepartamento de Cardiología, Instituto Cardiovascular Sanatorio MIGONE, Asunción, Paraguay.
Andrés Felipe Buitrago SandovalDepartamento de Cardiología, Fundación Santa Fe, Bogotá, Colombia.
María Lorena Coronel GilioDepartamento de Cardiología, Instituto de Cardiología J. F. Cabral, Corrientes, Argentina.
Freddy Pow Chon LongDepartamento de Cardiología, Hospital Luis Vernaza, Guayaquil, Ecuador.
Liliana Cárdenas AldazDepartamento de Cardiología, Hospital Eugenio Espejo, Quito, Ecuador.
Andrea ValenciaCentro de Investigaciones Clínicas, Fundación Valle del Lili, Cali, Valle del Cauca, Colombia.
Carlos Enrique Vesga-ReyesCentro de Investigaciones Clínicas, Fundación Valle del Lili, Cali, Valle del Cauca, Colombia.
Juan Esteban Gómez-MesaCentro de Investigaciones Clínicas, Fundación Valle del Lili, Cali, Valle del Cauca, Colombia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: COVID-19 can cause Myocardial Injury (MI) during acute illness, which has been strongly associated with worse outcomes during hospitalization, however, more research is required on its effects on long-term outcomes, especially in underexplored regions in the literature such as Latin America. Methods: This multicenter prospective cohort study follows up with patients with previous severe COVID-19 at a 2-year follow-up encounter. Comprehensive assessments were conducted including demographic data, clinical variables, psychiatric evaluations, and echocardiographic studies. Patients were stratified by the presence or absence of MI during their acute COVID-19 hospitalization. Statistical analyses included logistic regression and univariate comparisons. Results: Of the 210 patients included, 53 (25%) had MI. Patients with MI were older, had a higher prevalence of comorbidities (e.g., hypertension, chronic kidney disease, atrial fibrillation), and were more likely to require intensive care unit admission, invasive mechanical ventilation, and vasopressor or inotropic support during acute COVID-19. Regarding long-term cardiovascular outcomes, no significant differences were observed in Conclusion: Patients with prior MI during COVID-19 had a higher prevalence of comorbidities, poorer functional status, and increased odds of cardiopulmonary hospitalizations over a two-year follow-up evaluation compared to those without MI. Although prior studies suggest an association between MI and worse long-term outcomes, the evidence remains inconsistent. These findings emphasize the need for ongoing research to clarify how MI contributes to worsened long-term outcomes.

Indexed as

complicationsCOVID-19myocardial injuryprognosissurvivors

Identifiers

PMID40567826
PMCPMC12187653

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.